Sabra Healthcare Reit Stock Forecast

Sell candidate since Nov 13, 2025 Loss -0.48%

The Sabra Healthcare REIT stock price fell by -0.322% on the last day (Monday, 17th Nov 2025) from $18.65 to $18.59. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 2.62% from a day low at $18.31 to a day high of $18.79. The price has risen in 6 of the last 10 days and is up by 3.91% over the past 2 weeks. Volume has increased on the last day by 735 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $56.71 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.87% during the next 3 months and, with a 90% probability hold a price between $15.99 and $17.97 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

SBRA Signals & Forecast

The Sabra Healthcare REIT stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $18.85. On a fall, the stock will find some support from the long-term average at approximately $18.18. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, November 11, 2025, and so far it has fallen -2.97%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The stock had a Golden Star Signal on Thursday, April 10, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Sabra Healthcare REIT stock

Sabra Healthcare REIT finds support from accumulated volume at $18.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.480 between high and low, or 2.62%. For the last week, the stock has had daily average volatility of 1.86%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SBRA) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Sabra Healthcare REIT to open at $18.56, and during the day (based on 14 day Average True Range), to move between $18.36 and $18.82, which gives a possible trading interval of +/-$0.451 (+/-2.46%) up or down from last closing price. If Sabra Healthcare REIT takes out the full calculated possible swing range there will be an estimated 2.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $18.88 (1.56%) than the support at $18.20 (2.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Dividend Warning For SBRA

Notice for SBRA: Ex-dividend date was Monday 17th November, 2025. The dividend was $0.300.

Is Sabra Healthcare REIT stock A Buy?

Sabra Healthcare REIT holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.189 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $18.56 ( 0.143%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk